Annual Cash & Cash Equivalents
$4.58B$291.85M-5.99%
Summary
- Current Value
- As of today, GSK annual cash & cash equivalents is $4.58B, down -5.99% on
- Historical Performance
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years, down -47.39% over the past 5 years
- All-Time High Comparison
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on
- 3-Year Low Comparison
- GSK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GSK annual cash & cash equivalents is higher than 97.51% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% | |
| Quarterly Cash & Cash Equivalents | $4.54B | -21.6% | -47.4% | -31.7% | -58.0% | |
| Price | $50.90 | +36.2% | +39.3% | +30.2% | +14.4% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Total Liabilities | $60.75B | +4.6% | +0.9% | -25.5% | +19.4% | |
| Annual Working Capital | -$5.22B | +11.3% | -112.6% | -100.9% | -202.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.48B | N/A | -51.6% |
| 5Y | $9.48B | -51.6% | |
| All | $11.21B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.58B | at low | |
| 5Y | $4.58B | at low | |
| All | $37.03M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of GSK?
As of today, GSK annual cash & cash equivalents is $4.58B
What is 1-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -5.99% year-over-year
What is 3-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -51.65% over the past 3 years
How far is GSK annual cash & cash equivalents from its all-time high?
GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on December 31, 2009
How does GSK annual cash & cash equivalents rank versus sector peers?
GSK annual cash & cash equivalents is higher than 97.51% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly Cash & Cash Equivalents
$4.54B$40.96M-0.89%
Summary
- Current Value
- As of today, GSK quarterly cash & cash equivalents is $4.54B, down -0.89% on
- Historical Performance
- GSK quarterly cash & cash equivalents is down -21.57% year-over-year, down -47.35% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash & cash equivalents is currently -70.77% below its historical high of $15.54B set on
- 3-Year Low Comparison
- GSK quarterly cash & cash equivalents is +20.41% above its 3-year low of $3.77B reached on
- Sector Comparison
- GSK quarterly cash & cash equivalents is higher than 97.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.54B | -0.9% | -21.6% | -47.4% | -31.7% | |
| Annual Cash & Cash Equivalents | $4.58B | – | -6.0% | -51.6% | -47.4% | |
| Price | $50.90 | -13.1% | +36.2% | +39.3% | +30.2% | |
| Quarterly Current Assets | $23.42B | -0.6% | +0.3% | -3.9% | -8.4% | |
| Quarterly Total Liabilities | $59.93B | -1.3% | -1.3% | +2.5% | -23.9% | |
| Quarterly Working Capital | -$6.16B | -17.9% | -73.7% | -409.6% | -154.8% | |
| Quarterly Net Income | $2.48B | +156.3% | +11.0% | +25.0% | +42.6% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.79B | N/A | -21.6% |
| 3Y | $8.62B | N/A | -47.4% |
| 5Y | $10.37B | -56.2% | |
| All | $15.54B | -70.8% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.45B | +2.0% | |
| 3Y | $3.77B | +20.4% | |
| 5Y | $3.77B | +20.4% | |
| All | $37.03M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of GSK?
As of today, GSK quarterly cash & cash equivalents is $4.54B
What is GSK quarterly cash & cash equivalents most recent change?
GSK quarterly cash & cash equivalents was down -0.89% on March 31, 2026
What is 1-year change in GSK quarterly cash & cash equivalents?
GSK quarterly cash & cash equivalents is down -21.57% year-over-year
How far is GSK quarterly cash & cash equivalents from its all-time high?
GSK quarterly cash & cash equivalents is currently -70.77% below its historical high of $15.54B set on March 31, 2015
How does GSK quarterly cash & cash equivalents rank versus sector peers?
GSK quarterly cash & cash equivalents is higher than 97.51% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk